Image credit: EndeavorRx by Akili Interactive
Akili Interactive believes that effective medicine for serious illnesses can also be fun and engaging and is creating a new class of digital medicines for people living with cognitive impairment.
In the words of Eddie Martucci, Ph.D., chief executive officer of Akili:
"We’re bringing together world-class neuroscience with the latest technology and video game entertainment to challenge the status quo of medicine. Our digital medicine is not delivered through a pill or syringe, but rather through a proprietary and captivating video game experience."
Boston-based Akili has pioneered the development of video game-based digital medicine to improve cognitive function. Akili’s patented technology serves as the foundation of its products and is designed to directly activate the networks in the brain responsible for cognitive function. Driven by its value proposition, Akili’s treatments are delivered through action video game experiences that drive engagement and compliance.
The EndeavorRx treatment will be available with a
prescription to families soon. It will be released as the centerpiece of the
Endeavor Care Program, which includes the EndeavorRx treatment and Akili
CareTM, a mobile tracking app and personal support services for
caregivers. Easily accessible from home, EndeavorRx is downloaded from
the App Store by families on their mobile devices and does not require any
additional equipment.
Boston-based Akili has pioneered the development of video game-based digital medicine to improve cognitive function. Akili’s patented technology serves as the foundation of its products and is designed to directly activate the networks in the brain responsible for cognitive function. Driven by its value proposition, Akili’s treatments are delivered through action video game experiences that drive engagement and compliance.
Akili’s flagship product is EndeavorRX. The company has
just announced that the U.S. Food and Drug
Administration (FDA) permitted marketing of the first game-based digital
therapeutic to improve attention function in children with attention deficit
hyperactivity disorder (ADHD). The prescription-only video game is indicated
for pediatric patients ages 8 to 12 years old with primarily inattentive or
combined-type ADHD who have demonstrated an attention issue.
That is a landmark decision from the FDA, which is
authorizing doctors to prescribe the iPhone and iPad game for kids between ages
8 and 12 years old with ADHD, after it underwent almost a decade of clinical
trials that studied over 600 children to figure out whether a game could
actually make a difference.
According to the U.S. Food and Drug Administration, EndeavorRx
is indicated to improve attention function as measured by computer-based
testing and is the first digital therapeutic intended to improve symptoms
associated with ADHD, as well as the first game-based therapeutic granted
marketing authorization by the FDA for any type of condition. The game is
intended for use as part of a therapeutic program that may include
clinician-directed therapy, medication, and/or educational programs, which
further address symptoms of the disorder:
"The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “The FDA is committed to providing regulatory pathways that enable patients timely access to safe and effective innovative digital therapeutics.
EndeavorRx was granted permission
to market based on data from five clinical studies, including a prospective,
randomized, controlled study published in The
Lancet Digital Health journal, which showed EndeavorRx
improved objective measures of attention in children with ADHD.
Image credit: EndeavorRx
by Akili Interactive
The game sends players
through landscapes like a molten lava river and an icy winter wonderland,
rewarding them with stars and points as they finish tasks. Akili sees the video
game as a delivery system for targeted algorithms that can activate and strengthen
certain neural networks in the brain. It is more ambitious than the many
digital health apps and software programs that aim to help patients manage
medical conditions with education, tips, and reminders — and it’s long been
seen as a crucial test case for the potential of the sector.
Image credit: EndeavorRx
by Akili Interactive
Part of the Endeavor Care
Program